173 related articles for article (PubMed ID: 11979423)
1. Inhibition of acetylcholinesterase by physostigmine analogs: conformational mobility of cysteine loop due to the steric effect of the alkyl chain.
Gavuzzo E; Pomponi M
J Biochem Mol Toxicol; 2002; 16(2):64-9. PubMed ID: 11979423
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
5. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.
Ul-Haq Z; Mahmood U; Jehangir B
Chem Biol Drug Des; 2009 Dec; 74(6):571-81. PubMed ID: 19843075
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
[TBL] [Abstract][Full Text] [Related]
7. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
[TBL] [Abstract][Full Text] [Related]
8. The role of TRP84 in catalytic power and the specificity of AChE.
Pomponi M; Sacchi S; Colella A; Patamia M; Marta M
Biophys Chem; 1998 Jun; 72(3):239-46. PubMed ID: 9691268
[TBL] [Abstract][Full Text] [Related]
9. Hyperbolic mixed-type inhibition of acetylcholinesterase by tetracyclic thienopyrimidines.
Tanarro CM; Gütschow M
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):350-8. PubMed ID: 20807084
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AChE: structure-activity relationship among conformational transition of Trp84 and biomolecular rate constant.
Bertonati C; Marta M; Patamia M; Colella A; Pomponi M
J Enzyme Inhib; 2000; 15(6):547-56. PubMed ID: 11140610
[TBL] [Abstract][Full Text] [Related]
11. Physostigmine analogs anticholinesterases: effects of the lengthening of the N-carbamic chain on the inhibition kinetics.
Marta M; Gatta F; Pomponi M
Biochim Biophys Acta; 1992 Apr; 1120(3):262-6. PubMed ID: 1576152
[TBL] [Abstract][Full Text] [Related]
12. Analysis of electronic structures of physostigmine analogs.
Hu ZJ; Jiang HL; Chen JZ; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):322-6. PubMed ID: 10375776
[TBL] [Abstract][Full Text] [Related]
13. A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease.
Recanatini M; Cavalli A; Hansch C
Chem Biol Interact; 1997 Aug; 105(3):199-228. PubMed ID: 9291997
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
[TBL] [Abstract][Full Text] [Related]
15. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
[TBL] [Abstract][Full Text] [Related]
16. Phenserine Axonyx.
Thatte U
Curr Opin Investig Drugs; 2005 Jul; 6(7):729-39. PubMed ID: 16044670
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile.
Pietsch M; Christian L; Inhester T; Petzold S; Gütschow M
FEBS J; 2009 Apr; 276(8):2292-307. PubMed ID: 19292865
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
Yu Q; Greig NH; Holloway HW; Brossi A
J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibition by pitofenone: a spasmolytic compound.
Punekar NS; Kulkarni AV
Biotechnol Appl Biochem; 1991 Dec; 14(3):378-82. PubMed ID: 1777122
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholinesterase inhibition in vitro by huperzine analogs.
Tang XC; Xu H; Feng J; Zhou TX; Liu JS
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):107-10. PubMed ID: 8010100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
